Scinai Immunotherapeutics (SCNI) Non-Current Assets (2017 - 2026)

Scinai Immunotherapeutics (SCNI) has 10 years of Non-Current Assets data on file, last reported at $14.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets changed N/A year-over-year to $14.0 billion; the trailing twelve-month figure through Mar 2026 stood at $14.0 billion (changed N/A YoY), and the FY2025 full-year result was $9.6 billion, up 86469.59% from the prior year.
• Non-Current Assets grew to $14.0 billion in Q1 2026, from $9.6 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $14.0 billion in Q1 2026 to a low of $10.3 million in Q2 2025.
• A 5-year average of $1.7 billion and a median of $12.1 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets slipped 10.54% in 2022 and jumped 86469.59% in 2025, its largest moves.
• Tracing SCNI's Non-Current Assets over 5 years: stood at $12.7 million in 2022, then slipped by 5.29% to $12.0 million in 2023, then dropped by 8.05% to $11.1 million in 2024, then jumped by 86469.59% to $9.6 billion in 2025, then jumped by 45.99% to $14.0 billion in 2026.
• Business Quant data shows SCNI's Non-Current Assets at $14.0 billion in Q1 2026, $9.6 billion in Q4 2025, and $10.3 million in Q2 2025.